Giant cell myocarditis: Diagnosis and treatment

Herz

Volumn 37, Issue 6, 2012, Pages 632-636

  Cooper Jr , L T ^a   Elamm, C ^b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Bridge to transplantation; Heart failure; Heart transplantation; Immunosuppression; Myocarditis

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; CYTOKINE; PLAKOGLOBIN;

ARTICLE; ASSISTED CIRCULATION; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; DESMOSOME; GENOMICS; HEART BLOCK; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INTERSTITIAL MYOCARDITIS; LYMPHOCYTIC MYOCARDITIS; MECHANICAL CIRCULATORY SUPPORT; MOLECULAR PATHOLOGY; MYOCARDITIS; NONHUMAN; PATIENT CARE; PRACTICE GUIDELINE; PROGNOSIS; PROTEIN EXPRESSION; PROTEOMICS; RECURRENCE RISK; RECURRENT DISEASE; SURVIVAL TIME; TREATMENT OUTCOME;

CARDIOMYOPATHY, DILATED; GIANT CELLS; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MYOCARDITIS;

EID: 84867844534     PISSN: 03409937     EISSN: 16156692     Source Type: Journal    
DOI: 10.1007/s00059-012-3658-1     Document Type: Article

References (29)

1. Saltykow S (1905) Uber Diffuse Myokarditis Virchows Archiv fur Pathologische Anatomie 182:1-39
2. Costanzo-Nordin M, Silver M, O'Connell J, et al. (1987) Giant cell myocarditis: dramatic hemodynamic histologic improvement with immunosuppressive therapy. Eur Heart Suppl J 271-274
3. Davies M, Pomerance A, Teare R (1975) Idiopathic giant cell myocarditis - a distinctive clinico-pathological entity. Br Heart J 37:192-195
4. Okura Y, Dec GW, Hare JM, et al. (2003) A clincal and histopathologic comparison of cardiac sarcoidosis and idiopathic giant cell myocarditis. J Am Coll Cardiol 41:322-328
5. Kandolin R, Lehtonen J, Kupari M (2011) Cardiac sarcoidosis and giant cell myocarditis as causes of atrioventricular block in young and middle-aged adults. Circ Arrhythm Electrophysiol 4:303-309
6. Cooper LT Jr, Berry GJ, Shabetai R (1997) Idiopathic giant-cell myocarditis - natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators. N Engl J Med 336:1860-1866
7. Cooper L (2007) Giant cell myocarditis in children. Prog Pediatr Cardiol 24:47-49
8. Cooper LT Jr, Hare JM, Tazelaar HD, et al. (2008) Usefulness of immunosuppression for giant cell myocarditis. Am J Cardiol 102:1535-1539
9. Vaideeswar P, Cooper L (2012) Giant cell myocarditis: clinical and pathological disease characteristics in an indian population. Cardiovascular Pathology (in press)
10. Whitehead R (1965) Isolated myocarditis. Brit Heart J 27:220-230
11. Okada R, Wakafuji S (1985) Myocarditis in autopsy. Heart Vessels Suppl 1:23-29
12. Winters G, Costanzo-Nordin M (1991) Pathological findings in 2300 consecutive encomyocardial biopsies. Mod Pathol 441-448
13. Kodama M, Matsumoto Y, Fujiwara M, et al. (1990) A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction. Clin Immunol Immunopathol 57:250-262
14. Hirono S, Islam MO, Nakazawa M, et al. (1997) Expression of inducible nitric oxide synthase in rat experimental autoimmune myocarditis with special reference to changes in cardiac hemodynamics. Circ Res 80:11-20
15. Fuse K, Kodama M, Aizawa Y, et al. (2001) Th1/Th2 balance alteration in the clinical course of a patient with acute viral myocarditis. Jpn Circ J 65:1082-1084
16. Chang H, Hanawa H, Yoshida T, et al. (2008) Alteration of IL-17 related protein expressions in experimental autoimmune myocarditis and inhibition of IL-17 by IL-10-Ig fusion gene transfer. Circ J 72:813-819
17. Asimaki A, Tandri H, Duffy ER, et al. (2011) Altered desmosomal proteins in granulomatous myocarditis and potential pathogenic links to arrhythmogenic right ventricular cardiomyopathy. Circ Arrhythm Electrophysiol 4:743-752
18. Asimaki A, Tandri H, Huang H, et al. (2009) A new diagnostic test for arrhythmogenic right ventricular cardiomyopathy. N Engl J Med 360:1075-1084
19. Kittleson M, Minhas K, Irizarry R, et al. (2005) Gene expression in giant cell myocarditis: Altered expression of immune response genes. Int J Cardiol 102:333-340
20. Cooper L, Onuma O, Sagar S, et al. (2010) Genomic and proteomic analysis of myocarditis and dilated cardiomyopathy. Heart Fail Clinics North America 6:75-85
21. Shields RC, Tazelaar HD, Berry GJ, Cooper LT Jr (2002) The role of right ventricular endomyocardial biopsy for idiopathic giant cell myocarditis. J Card Fail 8:74-78
22. Cooper LT, Baughman KL, Feldman AM, et al. (2007) The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation 116:2216-2233
23. Mason JW, O'Connell JB, Herskowitz A, et al. (1995) A clinical trial of immunosuppressive therapy for myocarditis. N Engl J Med 333:269-275
24. Das B, Recto M, Johnsrude C, et al. (2006) Cardiac transplantation for pediatric giant cell myocarditis. J Heart Lung Transplant 25:474-478
25. Cooper L, Orellana V, Schultheiss H-P, et al. (2012) Long term risk of death, transplantation, and disease recurrence in giant cell myocarditis. J Am Coll Cardiol 59:E1547 (Abstract)
26. Brilakis E, Olson L, Berry G, et al. (2000) Survival outcomes of patients with giant cell myocarditis bridged to transplantation with ventricular assist devices. ASAIO J 46:569-572
27. Murray LK, González-Costello J, Jonas SN, et al. (2012) Ventricular assist device support as a bridge to heart transplantation in patients with giant cell myocarditis. Eur J Heart Fail 14(3):312-318
28. Scott R, Ratliff N, Starling R, Young J (2001) Recurrence of giant cell myocarditis in cardiac allograft. J Heart Lung Transplant 20:375-380
29. Davies RA, Veinot JP, Smith S, et al. (2002) Giant cell myocarditis: clinical presentation, bridge to transplantation with mechanical circulatory support, and long-term outcome. J Heart Lung Transplant 21:674-679